home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Genes, Clones & Patents - Intellectual Property and the Biological Revolution

 
  November 28, 2006  
     
 


University of Oxford, UK
21 - 23 March 2007


This course is an introduction to modern developments in molecular biology and genetic engineering and a discussion of recent developments in the law of patents.

The scientific sessions will consider DNA and its replication and expression in both bacteria and higher cells; regulation, differentiation and development; cloning; genetic libraries and screening techniques; and characterizing and altering cloned DNA.

The legal sessions will focus on various aspects of patent law in the field of biotechnology, particularly following the judgment in the Kirin-Amgen v TKT case.

Who is it for?
This course will be of particular interest to those working in the Intellectual Property departments of pharmaceutical and biotechnology companies; to patent agents and patent lawyers, both from the UK and from elsewhere in Europe; to research biologists with an interest in the legal consequences of developments in modern biology; and to those interested in financing and developing biotechnological industries.

 
 
Organized by: University of Oxford BioSciences
Invited Speakers: Professor Michael Yudkin, Emeritus Professor of Biochemistry at the University of Oxford

Dr Chris Norbury, Lecturer in the Sir William Dunn School of Pathology at the University of Oxford

Gregor Grant, partner with Marks & Clerk Solicitors

 
Deadline for Abstracts: n/a
 
Registration: Click here for registration
E-mail: cpdbio@conted.ox.ac.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.